Finally, the analysis of the combination of NPC1L1 expression and tumor stage demonstrated that although tumor stage is a critical prognostic indicator, high NPC1L1 expression also significantly influences patient outcomes, providing additional prognostic value beyond traditional staging factors. This evidence concerns the gene NPC1L1 and neoplasm.